Vaccination after Covid-19 Recovery | NEJM

Podcast 282: Vaccination after Covid-19 recovery prolongs natural immunity to reinfectionПодробнее

Effectiveness of Covid-19 Vaccine in Adolescents | NEJMПодробнее

BNT162b2 Covid-19 Vaccine in 5-to-11-Year-Olds | NEJMПодробнее

mRNA Covid-19 Vaccination in U.S. Health Care Personnel | NEJMПодробнее

Vaccine for COVID-19 | NEW Paper NEJM with Phase I Clinical Trial for mRNA-1273 Coronavirus VaccineПодробнее

VV116 for Oral Treatment of Covid-19 | NEJMПодробнее

Vaccines Update, NEJM Weighs InПодробнее

Podcast 283: More data — this time from the U.K. — about post-Covid vaccinationПодробнее

Oral Molnupiravir to Treat Mild-to-Moderate Covid-19 | NEJMПодробнее

COVID-19 vaccine Q&A #5: How long is the recovery time after getting the vaccine?Подробнее

Ivermectin Together Trial Results from NEJMПодробнее

Molnupiravir NEJM Study - 58th COVID UpdateПодробнее

Novavax, Nasal Rinse, Vaccine Efficacies and More NewsПодробнее

Novavax Phase IIIb UK Trial ResultsПодробнее

The COVID Vaccine: When Will It Be Ready?Подробнее

Sotrovimab for Early Covid 19 NEJMПодробнее

One vaccine dose and two viral variantsПодробнее

Excellent vaccine results, takes timeПодробнее